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This article discusses the current needs and trends  
in wound care with particular reference to future trends 
in diagnostics and provides examples of some 
emerging techniques. 
Across the globe the increasing prevalence of diabetes and 
cardiovascular disease, and the rise in the number of elderly 
people in the populations of developed countries are driving 
growth in wound care treatments, and increasing the burden 
of problems in wound management. 
The exact global incidence and costs of wound care, plus the 
additional costs incurred when wounds become infected, are 
difficult to determine exactly due to differences in wound care 
within and between countries and differences in how wound 
care costs are categorised within health services. 
Studies in different regions indicate that wound care is a 
significant cost to healthcare providers, however. As an 
example, we can consider some reports in the literature 
related to the UK, illustrating the scale of the problem in a 
developed country of some 60 million people. Posnett and 
Franks (2007) reviewed the literature from the UK wound care 
community and estimated the incidence and costs of common 
chronic wounds for the year 2005/2006. The incidence and 
costs are summarised in Table 1.
Overall, the total estimated cost of chronic wound care in the 
UK for the year 2005/2006 was £2.3 billion to £3.1 billion, and 
this is likely to increase as the UK population increases. This 
trend will be mirrored in other countries and thus it is clear that 
governments will find that wound care is a significant part of 
their healthcare costs. In addition to chronic wound care 
costs, there are costs associated with other acute wound 
types, for example burns and post surgical care.
The other area of interest globally in wound care is that of 
wound infection. This again is largely studied on a regional or 
per hospital basis by centres for infection control or other 
interested bodies. It is clear from the media and literature that 
Hospital Acquired Infections (HAIs) are problematic in most 
healthcare systems, and the public have an increased 
awareness and concern about this. 
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Wound Type Incidence Cost per patient Total annual cost
Venous leg ulcer 108,600 £1,549-£1,822 £168 million - 198 million
Pressure ulcer 370,000 - 460,000 £4,300-£6,400 £1.76 billion - 2.64 billion
Diabetic ulcer 63,700 £4,710 £300 million
Total cost £2.3 billion - 3.1 billion
Table 1. Estimated incidence and costs of chronic wounds in the UK in 2005/2006
One route for HAIs to enter the body is via a wound, either 
through surgical site infection or by cross infection during 
wound treatment by hospital staff. A significant proportion  
of HAIs are wound related. Again, looking at the UK as an 
example, a survey in Scotland in 2005/2006 indicated that  
the prevalence of all types of HAIs among patients was  
9.50% for acute hospitals and 7.32% for non-acute hospitals 
(Reilly et al, 2008). 
“better diagnostics for wounds 
would provide the possibility of 
earlier intervention, better dressing 
selection and improved wound 
care protocols for patients”
Of these HAIs 15.8% and 3.0% were surgical site infections  
in acute and non-acute hospitals respectively, and 11.0% and 
26.8% of all HAIs were soft tissue or skin infections. A similar 
survey of HAIs for England, Wales, Northern Ireland and the 
Republic of Ireland in 2006 indicates that the prevalence of 
HAIs among patients was between 5.43% and 8.19%  
(Smyth et al, 2008). From a wound care perspective the 
percentage of these HAIs that were surgical site infections was 
between 0.5% and 11.7%, and the remainder were soft tissue 
or skin infections of between 11.0% and 26.8% of all HAIs. 
Thus there are two areas of concern for healthcare providers: 
firstly how to best manage wound care in a large and growing 
population of patients with a range of chronic and acute 
conditions; and secondly, how to reduce infection and manage 
infected wounds. 
The availability of better diagnostics for wounds would  
provide the possibility of earlier intervention, better dressing 
selection and improved wound care protocols for patients. 
This in turn would reduce costs and staff time due to better 
use of dressings, possibly fewer dressing changes and more 
treatments being tailored to the individual patient’s needs.  
To understand what types of diagnostics can improve wound 
care it is useful to consider the current best practise in wound 
healing and in diagnosis of infection. 
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Best practise - 
clinical guidelines
Acute wounds normally heal through four phases: 
haemostasis, inflammation, proliferation and remodelling. 
These phases occur within a specific time frame dependent  
on the severity of the wound. Chin et al (2005), and Johnstone 
et al (2007) provide a more detailed account of these phases.
Clinical intervention can help the healing process, depending 
on the type of wound. There are three clinical methods by 
which wounds are healed: in primary intention the wound 
edges are held together by sutures, staples or glue; with 
secondary intention the wound is left open to allow the 
formation of granulation tissue and epithelialisation; and tertiary 
intention is a combination in which the wound is left open for 
several days to remove contamination before bringing the 
edges together.
In effective healing of a wound several parameters are 
important. The wound bed is an important aspect in wound 
healing since this is the physical and biochemical base that  
the wound has to heal from. In optimal treatment any 
underlying diseases must be treated, an adequate blood 
supply to the wound should be ensured, and the wound 
history and characteristics should be assessed and monitored 
(Schultz et al, 2005). 
“an adequate blood supply to the 
wound should be ensured, and 
the wound history and 
characteristics should be 
assessed and monitored”
The wound bed should then be managed by debridement, 
exudate management and controlling bacterial growth. An 
important framework for the preparation of the wound bed, 
based on systematic management of non-healing wounds, 
was developed by the International Wound Bed Advisory 
Board (Schultz et al, 2005). This framework was given an 
acronym TIME and these terms were further developed by the 
European Wound Management Association (EWMA, 2004). 
The TIME framework is listed in Table 2.
Traditionally, it was thought that exuding wounds should be 
kept as dry as possible to prevent bacterial infection, which 
was common practise up until and including the late 1950s. 
This involved applying highly absorbent materials, removing  
as much exudate as possible from the wound. This approach 
was first challenged by research conducted by Winter (1962) 
and others thereafter who demonstrated in both pigs and 
humans that wounds that were kept moist healed more rapidly 
than those that were left uncovered, or treated with traditional 
highly absorbent dressings.
Under the traditional arid conditions the wound dehydrates 
resulting in the formation of a scab, or eschar, consisting  
of dried serous exudate and a layer of devitalised dermis.  
This scab provides an effective barrier to migrating epidermal 
cells, which forces the cells deeper under the scab. This 
effectively increases the healing time and may cause the  
loss of healthy tissue.
Another aspect of dressing choice and wound monitoring  
is that  the dressing could adhere or become bound to  
the wound surface as the wound dries. In this situation 
considerable damage would be inflicted upon the delicate 
healing tissue when the dressing is removed.  
It is possible to prevent the formation of a scab by application 
of an occlusive dressing. This means that the wound under 
the dressing is moist, allowing the rapid movement of epithelial 
cells across the surface of the dermis through the wound 
exudate at the surface of the wound.  
Although it is desirable that the wound should remain 
hydrated, excessive pooling of liquid under the wound 
dressing should also be avoided. This can cause further 
damage to the wound as it can result in maceration, which 
leads to the breakdown of skin barrier function and causes 
additional pain (Cutting and White, 2002) to the patient.  
In addition, excessive liquid can result in ‘strike through’  
of fluid to the outer surface of the wound dressing. This 
provides a pathway for bacteria to pass through the dressing 
into the wound, reducing the protective barrier function of the 
wound dressing.
“a wide range of dressings is  
now available including dressings 
based on foam, alginates, silver 
and hydrocolloids”
Thus in recent years the market in wound care has centred 
upon ‘advanced moisture control dressings’ and additionally, 
dressings with slow release antimicrobials such as silver 
dressings. A wide range of dressings is now available to the 
wound care clinician and these include dressings based on 
foam, alginates, silver and hydrocolloids. A report by Krasner 
et al, 2010, contains helpful descriptions of modern dressings 
and summarises the key issues in dressing selection.
Infected wounds
Once a wound is present it will become contaminated either 
by microbes from the host’s body, from airborne dust or water 
droplets, or from contact with clothes, equipment and carers. 
The level of bacteria in a wound advances from contamination 
to colonisation and then infection, in which the bacteria 
overwhelm the immune system and this can lead to systemic 
infection, septicaemia, bacteraemia, and death. 
WOUND CARE
TIME elements Pathophysiology Suggested treatment Clinical result
Tissue 
management
Defective matrix and 
debris inhibit healing
Debridement Viable wound base
Inflammation and 
infection control
High bacterial 
counts/prolonged 
inflammation
Topical or systemic:
Antimicrobials
Anti-inflammatories
Protease inhibitors
Bacterial balance 
and reduced 
inflammation
Moisture balance
Desiccation or 
maceration
Moisture balancing 
dressings  
Negative pressure  
Remove fluid
Correct moisture 
balance
Epithelial (edge) 
advancement
Epithelial cells not 
migrating
Wound cells not 
responsive
Reasses cause
Corrective therapies
Advancing 
epidermal margin
Table 2. The TIME framework for wound bed preparation
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The European Wound Management Association position paper 
on wound infection (EWMA, 2005) identifies the three stages 
of infection in a wound as shown in Table 3. 
Diagnostics
It is only relatively recently that the field has started to develop 
notable scientific interest in the more complex aspects of 
wound diagnostics beyond swabbing for bacterial infection. 
Given the complexity of wounds and the variation in healing 
between individuals, there is a need for more diagnostic 
parameters of relevance to be measured and considered in 
the healing of complex wounds. 
Currently there is a real lack of analytical tools available to 
assess the real time status of wounds and at present clinicians 
still rely largely on skilled observations to evaluate the healing 
stage of a wound. 
In terms of parameters that are of interest in the healing 
wound these divide between biomarkers and physical 
parameters. Among the biomarkers there is interest in 
measuring a range of parameters in wound exudate and 
tissue, including bacterial load and species, enzyme activity 
(particularly metalloproteases), growth factors, hormones and 
cytokines. The physical parameters of interest include wound 
moisture, temperature and pH.  
Current situation in 
wound diagnostics
Analytical measurements such as wound pH, accurate wound 
sizing and moisture balance would enable an objective 
measurement of healing to provide the clinician with the most 
efficient and effective techniques to heal the wound. 
For infected wounds, products that will enhance clinical 
decision making and intervention need to be able to quickly 
distinguish bacteria early enough in the colonisation phase, 
and indicate that bacteria is not only growing, but is reaching 
‘critical colonisation’ and getting ready to fully infect the host. 
Thus products need to be able to quantify bacterial load, be 
portable and require minimal sample volumes. Of the products 
currently available that use advanced technology to speed up 
and improve accuracy of bacterial tests, the leaders are those 
using molecular diagnostic techniques.  
The suppliers in this field range from multinationals to 
emerging SMEs with new molecular detection techniques. 
They are in competition to some extent with the lateral flow 
assay companies, but lateral flow assays have less sensitivity  
if they are rapid, point of care tests. 
There is also a growing interest in wound dressings that can 
detect infection and react to it, including dressings that change 
colour in the presence of bacteria. There are as yet no medically 
approved dressings on the market for direct detection of 
bacteria in the dressing so it remains to be seen if these 
technologies will be developed fully for the commercial sector.
Although rapid diagnostics of wound markers and status is  
an emerging field in wound management there are some  
new tools already available, and some are given below as 
examples. There are a significant number of additional device 
technologies coming into the field and the range of such 
devices for wound diagnostics is discussed in detail by 
Dargaville et al, 2013, in their recent review of sensors for  
wound diagnostics. 
In terms of the metalloprotease enzymes a colour change test 
has now been developed that is commercially available 
(Serena et al, 2011). For this test the clinician samples wound 
exudate onto a membrane system at the time of dressing 
changes. Elevated protease levels may indicate the need for 
intervention with specialised dressings. 
In our laboratory, in the Department of Biomedical Engineering 
at the University of Strathclyde, we have a programme to 
develop a range of real time diagnostic sensors for wound 
management, including sensors that can be incorporated into 
any wound dressing. For example, the hydration status of a 
wound or wound dressing can be measured by reading a low 
voltage, low current electrical signal which detects the 
presence of moisture. 
We have developed a small, disposable sensor based on this 
principle that can be placed inside any wound dressing. The 
sensor detects dry, wet and optimal wetness states on healing 
wounds without the need to disturb the dressing, using a hand 
held meter that is connected to the dressing as required 
(McColl et al 2007).  
This saves staff time and costs on unnecessary dressing 
changes, reduces pain and trauma for patients, and limits 
opportunities for infection of the wound. The system is CE 
marked and already in use in the UK, Saudi Arabia and Qatar. 
The system’s hand held meter reports five moisture levels 
measured by the sensor on a five drop scale. These are:
1. Wet 
2. Wet to moist 
3. Moist 
4. Moist to dry 
5. Dry  
Further research
Clearly in a diagnostics platform other parameters would be  
of interest for wound care. Bacterial sensing and pH sensing 
are both being pursued in our research work. 
In a new collaborative project with Hamad Medical 
Corporation, funded by the Qatar National Research Fund,  
we are researching a disposable pH sensor for wound  
exudate monitoring. 
The pH of the wound environment can help or hinder wound 
healing. There is a demand from the clinical community to 
have immediate pH information about patients’ wounds during 
wound dressing changes, but to date no usable sensor has 
WOUND CARE
Contamination – All wounds may acquire microorganisms.  
If suitable nutritive and physical conditions are not available for each 
microbial species, or they are not able to successfully evade host 
defences, they will not multiply or persist; their presence is therefore 
only transient and wound healing is not delayed.
Colonisation – Microbial species successfully grow and divide,  
but do not cause damage to the host or initiate wound infection.
Infection – Microbial growth, multiplication and invasion into host 
tissue leads to cellular injury and overt host immunological reactions. 
Wound healing is interrupted. Local factors can increase the risk  
of infection.
Table 3. EWMA infection stages
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come to market. Wound pH is considered important as an 
indicator for health of the tissue environment, inflammatory 
status and presence of bacteria, but it has not been possible 
to extensively study patient populations to confirm this due to 
the difficulty of using traditional pH measurement systems in 
the wound environment. 
In addition, if a real time bacterial sensor can be developed for 
use within a dressing then early warning of an infection will 
allow a clinical care giver to intervene in a timely manner with 
drug and dressing therapies that can prevent the infection 
from taking hold in the wound. 
We have conducted several in vitro bacterial growth studies to 
test the hypothesis that we can monitor the growth of bacteria 
in situ through electrical impedance signatures. The ultimate 
objective of this research is to develop a system that consists 
of a sensor that can be placed on the wound surface 
underneath the dressing. Ideally measurements would then  
be performed with a handheld device to return an immediate 
analysis of the bacterial environment. Early indications from our 
studies in bacterial broths are encouraging (Farrow et al, 2012) 
and the work continues. 
Conclusions
In summary, the field of wound treatment is facing a growing 
burden of patients, but wound diagnostics is advancing and 
we can expect to see more diagnostic tools and parameters 
becoming available to the clinical community. This is a 
multidisciplinary field requiring interactions between clinicians, 
engineers and life scientists and therefore complex, but 
worthwhile as it will bring benefits to clinicians, patients  
and healthcare providers. 
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